Gln27Glu β2-adrenergic receptor variant is associated with hypertriglyceridemia and the development of fatty liver
- 31 December 2001
- journal article
- Published by Elsevier in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 314 (1-2) , 85-91
- https://doi.org/10.1016/s0009-8981(01)00633-7
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Body Composition and Hepatic Steatosis As Precursors for Fibrotic Liver DiseaseHepatology, 1999
- A Mutation in the β3-Adrenergic Receptor Gene Is Associated with Obesity and Hyperinsulinemia in Japanese SubjectsBiochemical and Biophysical Research Communications, 1995
- Association of a Polymorphism in the β3-Adrenergic–Receptor Gene with Features of the Insulin Resistance Syndrome in FinnsNew England Journal of Medicine, 1995
- Time of Onset of Non-Insulin-Dependent Diabetes Mellitus and Genetic Variation in the β3-Adrenergic–Receptor GeneNew England Journal of Medicine, 1995
- Genetic Variation in the β3-Adrenergic Receptor and an Increased Capacity to Gain Weight in Patients with Morbid ObesityNew England Journal of Medicine, 1995
- Demonstration of an in vivo functional beta 3-adrenoceptor in man.Journal of Clinical Investigation, 1995
- The biochemistry of alcohol-induced fatty liverBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1994
- Nonalcoholic steatohepatitis: An expanded clinical entityGastroenterology, 1994
- Lipolytic catecholamine resistance due to decreased beta 2-adrenoceptor expression in fat cells.Journal of Clinical Investigation, 1992
- Liver in obesity.Gut, 1985